E0018
Epidermal Growth Factor Receptor (EGFR) Hotspot Mutations: Exons 19 & 21
| Number of Tests | 2 |
| Test Included | Exon 19, Exon 21 |
Test Details: Mutations in the EGFR gene correlate with clinical responsiveness to the TK inhibitor. In majority of patients with highly responsive tumors, the tumor contains somatic mutation of the EGFR gene. Screening for the mutation in the lung cancer helps to stratify patient responsiveness to Gefitinib and Erlotinib.
Category
Molecular Genetics
Pre-test Information
H & E report, grossing details, duration of fixation, clinical details and site of lesion / biopsy is required.
Report Delivery
4 working days
Gender
All
Organ
Multi-Organ
Epidermal Growth Factor Receptor (EGFR) Hotspot Mutations: Exons 19 & 21
6820
Most Searched Diagnostic Tests